TOKYO -- The Japanese government is planning to ease regulations for medical artificial intelligence software to boost the domestic market, Nikkei has learned.
The government is considering cutting the need for regulatory approval to update such software as early as by the end of 2022. This will make it easier for companies to improve software performance and to detect diseases more quickly. The medical software market is dominated by foreign companies, and the deregulation is aimed at helping the domestic market recover.
